feed,title,long_url,short_url
Benzinga,Report: Gilead Sciences And Cancer Treatment Company Immunomedics In $20B Deal,https://www.benzinga.com/general/biotech/20/09/17480118/report-gilead-sciences-and-cancer-treatment-company-immunomedics-in-20b-deal,https://j.mp/35xPeuq
